Amylin (AMLN), Eli Lilly (LLY) and Alkermes (ALKS) Said Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control with Weight Loss Over Two Years
Tweet Send to a Friend
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY), and Alkermes, Inc. (Nasdaq: ALKS) announced long-term, interim results ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
